NCT06670209View on ClinicalTrials.gov

A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

March 19, 2025

Study Completion Date

March 19, 2025

Conditions
Type 2 Diabetes
Interventions
DRUG

GZR18 and metformin

GZR18: 3 mg-18 mg Metformin: 500 mg

Sponsors
All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY